Cafepharma Today

January 23 2024 - AbbVie pulls off a hat trick with 3rd straight year as top TV drug ad spender
AbbVie pulls off a hat trick with 3rd straight year as top TV drug ad spender
FDA tacks boxed warning on Teva’s Copaxone, other MS drugs
RFK Jr. plans to keep a financial stake in lawsuits against the drugmaker Merck
Biogen research team hit by layoffs as company shifts resources to external opportunities
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Breast Cancer Risk Falls After Stopping Hormone-Replacement Therapy
WSJ Online
Monday, December 15, 2008 - 9:40am
tags:
breast cancer, Wyeth, HRT
MDRNA, Inc. Announces Tentative FDA Approval of Generic Calcitonin-Salmon Nasal Spray for Osteoporosis
Yahoo
Monday, December 15, 2008 - 9:28am
tags:
MDRNA, osteoporosis, Miacalcin, Novartis
The Long Campaign for FDA Commissioner
InVivo
Monday, December 15, 2008 - 9:19am
tags:
FDA
Infosys wins multi-million dollar deal from AstraZeneca
Yahoo/AP
Monday, December 15, 2008 - 9:16am
tags:
AstraZeneca, Infosys, India
Genentech and Generex: New HER2/neu Research
Seeking Alpha
Monday, December 15, 2008 - 8:20am
tags:
Genentech, Generex, breast cancer
BioDelivery Sciences resubmits Onsolis NDA to FDA
RTT News
Monday, December 15, 2008 - 8:10am
tags:
BioDelivery Sciences, Onsolis
Biotechs With Breakthroughs Can Spurn Product-Hungry Drugmakers
Bloomberg
Monday, December 15, 2008 - 8:07am
tags:
Eli Lilly, Bayer, Genmab, Basilea, Actelion
Elan Shareholder Wants CEO To Go
Pharmalot
Monday, December 15, 2008 - 7:38am
tags:
Kelly Martin, Elan
Why ARIAD Pharmaceuticals Needs an SEC Investigation
Seeking Alpha
Monday, December 15, 2008 - 7:37am
tags:
Ariad Pharmaceuticals, SEC
Illumina Added to NASDAQ-100 Index
Yahoo
Monday, December 15, 2008 - 7:02am
tags:
Illumina, NASDAQ
Lundbeck moves to Phase III with alcoholism drug
Reuters
Monday, December 15, 2008 - 6:20am
tags:
nalmefene, Lundbeck
Roche’s Xeloda Medicine Keeps Breast Cancer at Bay in Study
Bloomberg
Monday, December 15, 2008 - 6:16am
tags:
Roche, breast cancer, Xeloda
Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA)
SYS-CON Media, NJ
Sunday, December 14, 2008 - 12:27pm
tags:
EXPAREL, DepoBupivacaine, Pacira
China Biotech in Review: Innovation Dominates the News
Seeking Alpha
Sunday, December 14, 2008 - 12:24pm
tags:
China
End of painful jabs is just a breath away
Scottsman, UK
Sunday, December 14, 2008 - 12:19pm
tags:
XstalBio
BioTalk: Novartis' MS Play (video)
The Street
Sunday, December 14, 2008 - 12:15pm
tags:
Novartis, MS, multiple sclerosis
ABRAXANE in Combination with Gemcitabine and Epirubicin Evaluated as Neoadjuvant Treatment for Patients with Locally Advanced Breast Cancer
Yahoo
Sunday, December 14, 2008 - 12:12pm
tags:
companies, Abraxane, breast cancer
Bristol Talks the Talk in Mandarin
Seeking Alpha
Saturday, December 13, 2008 - 1:06pm
tags:
China, Bristol-Myers Squibb
Schering-Plough hepatitis C drug approved for kids
Yahoo
Saturday, December 13, 2008 - 12:59pm
tags:
hepatitis C, Schering Plough, PEG-Intron
Bristol-Myers joins Exelixis for cancer drugs
San Francisco Chronicle
Saturday, December 13, 2008 - 12:47pm
tags:
Exelixis, cancer, Bristol-Myers Squibb

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline
The Current Environment
In the Pipeline
Informa Connect's Patient Assistance & Access Programs (PAP)
Drug Channels
2025 Brand Drug Challenges: A GoodRx Perspective
Drug Channels
Snake Antivenoms, Computed
In the Pipeline
Versatile Chaperones
In the Pipeline
Dealing With Being a Tumor Cell
In the Pipeline
Why 340B Reform Could Happen in 2025 (video)
Drug Channels

Latest Jobs

Onsite Endoscopic Specialist - Operating Room Support
Santa Monica, California
KARL STORZ Endoscopy - America
Area Manager, Immunology Rochester, NY Territory
Fields, Oregon, 97710
CSL Behring
Psychiatry Account Manager - Tarrytown, NY
Tarrytown, New York
Lundbeck
Area Manager Specialty, West- Central
Fields, Oregon, 97710
CSL Behring
Area Sale Manager, Immunology Tampa North
Fields, Oregon, 97710
CSL Behring
Sales Representative
Boise, Idaho, 83708
Bartlett Roofing
Capital Project Manager
Carteret, New Jersey, United States
The Spear Group
Area Manager Specialty, West
Fields, Oregon, 97710
CSL Behring
Psychiatry Account Manager - Midland, TX
Midland, Texas, 79701
Lundbeck
Home Health and Medical Sales
The Woodlands, Texas, 77381
Comfort Keepers of Dallas TX
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information